Evaluation of Lipid Profile and Intima Media Thickness in Antiretroviral-Experienced HIV-Infected Patients Treated with Protease Inhibitor-Based Regimens versus Protease Inhibitor-Sparing Regimens

Background: Antiretroviral therapy has increasingly improved management of HIV infection, ensuring long-term efficacy and tolerability. Each class of antiretrovirals has, however, different characteristics and different tolerability profiles. The literature data show that protease inhibitors (PIs) a...

Full description

Bibliographic Details
Main Authors:	Salvatore Martini, Mariantonietta Pisaturo, Antonio Russo, Maria Grazia Palamone, Maria Teresa Russo, Verdiana Zollo, Paolo Maggi, Nicola Coppola
Format:	Article
Language:	English
Published:	MDPI AG 2023-07-01
Series:	Pathogens
Subjects:	HIV PIs IMT dyslipidemia CVD
Online Access:	https://www.mdpi.com/2076-0817/12/7/925

Similar Items

Susceptibility of HPV-18 Cancer Cells to HIV Protease Inhibitors
by: Lilian Makgoo, et al.
Published: (2024-10-01)

Inhibition of Chilo partellus (Lepidoptera: Pyralidae) gut proteases with Ipomoea batatas inhibitors
by: Balaji Panchal, et al.
Published: (2016-09-01)

Treatment Outcome and Regimens of Lipid-Lowering Drugs among HIV-Infected Patients Receiving Protease Inhibitors
by: Krisda Boonthos, et al.
Published: (2016-10-01)

Comparison of Integrase Strand Transfer Inhibitors (INSTIs) and Protease-Boosted Inhibitors (PIs) on the Reduction in Chronic Immune Activation in a Virally Suppressed, Mainly Male Population Living with HIV (PLWH)
by: Thomas Nitsotolis, et al.
Published: (2024-02-01)

Increased VLDL-apoB and IDL-apoB production rates in nonlipodystrophic HIV-infected patients on a protease inhibitor-containing regimen
by: Jean Michel Petit, et al.
Published: (2003-09-01)

Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens.
by: Luis F López-Cortés, et al.
Published: (2016-01-01)

Effectiveness of a early initiation of protease inhibitor-sparing antiretroviral regimen in human immunodeficiency virus-1 vertically infected infants
by: Maes Philip, et al.
Published: (2008-04-01)

Serum TSH level in obese children and its correlations with atherogenic lipid indicators and carotid intima media thickness
by: Małgorzata Rumińska, et al.
Published: (2018-12-01)

ALK inhibitors, a pharmaceutical perspective
by: Arturo eGalvani, et al.
Published: (2012-02-01)

Relationship of carotid intima-media thickness and duration of vegetarian diet in Chinese male vegetarians
by: Liu Chang-Qin, et al.
Published: (2011-09-01)

ROLE OF INTIMA-MEDIA THICKNESS (IMT) IN CAROTID ARTERY DOPPLER IN PREDICTING CAD AND ITS CORONARY ANGIOGRAPHY CORRELATIONRole of Intima-Media Thickness (IMT) in Carotid Artery Doppler in Predicting CAD and its Coronary Angiography Correlation
by: Raj J Soni, et al.
Published: (2020-06-01)

High sensitivity C-reactive protein as a predictive of intima-media thickness in patients with end-stage renal disease on regular hemodialysis
by: Lestariningsih L, et al.
Published: (2019-06-01)

Using structural equation modeling and intima-media complex texture features to assess cardiovascular disease risk in the common carotid artery
by: George Evripides, et al.
Published: (2024-12-01)

Complex contaminant mixtures and their associations with intima-media thickness
by: Eric N. Liberda, et al.
Published: (2019-12-01)

Prevalence and risk factors of carotid intima-media thickness in asymptomatic individual subjects in a tertiary care center in India
by: Subhash Kaul, et al.
Published: (2015-01-01)

Impacto da exclusão do ICMS da base de cálculo do PIS e da COFINS: estudo sobre a decisão do STF e seus efeitos em uma empresa do segmento alimentício
by: Jéssica Andressa Zago, et al.
Published: (2022-01-01)

Impact of the exclusion of ICMS from PIS and COFINS calculation base: study on the STF decision and its effects on a food company
by: Jéssica Andressa Zago, et al.
Published: (2022-01-01)

Bezpieczeństwo energetyczne Polski w założeniach programowych Prawa i Sprawiedliwości
by: Patryk Tomaszewski
Published: (2011-07-01)

Fasting levels of growth hormone are associated with carotid intima media thickness but are not affected by fluvastatin treatment
by: Erik Hallengren, et al.
Published: (2017-05-01)

Response to a Protease-Inhibitor (Ritonavir)-Containing Combination Antiretroviral Regimen in HIV-Infected Children
by: Upton D Allen, et al.
Published: (2003-01-01)

Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens.
by: Alexandra U Scherrer, et al.
Published: (2012-01-01)

The Level of Intima-Media Thickness in Patients with Metabolic Syndrome in Poland Depending on the Prevalence of Type 2 Diabetes
by: Marcin Gierach, et al.
Published: (2023-05-01)

Editorial: New frontiers in HIV antiretroviral treatment: from the management of metabolic complications and chronic inflammation to new long-acting regimens
by: Salvatore Martini, et al.
Published: (2024-04-01)

Inflammatory myofibroblastic tumor of the adrenal gland: A case report
by: Jiyao Yang, et al.
Published: (2024-07-01)

Naringin abrogates HIV-1 protease inhibitors-induced atherogenic dyslipidemia and oxidative stress in vivo
by: Sanelisiwe Nzuza, et al.
Published: (2019-01-01)

Increased acquired protease inhibitor drug resistance mutations in minor HIV-1 quasispecies from infected patients suspected of failing on national second-line therapy in South Africa
by: Adetayo Emmanuel Obasa, et al.
Published: (2021-02-01)

Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observational cohort study (SCOLTA)
by: Lucia Taramasso, et al.
Published: (2018-07-01)

A rare phenomenon of atypical lipodystrophy in a patient on HAART in the absence of a protease inhibitor regimen
by: Mohammed Mitha, et al.
Published: (2010-11-01)

Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children
by: Soriano Vincent, et al.
Published: (2007-06-01)

Correction: Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens
Published: (2013-01-01)

Association of marine PUFAs intakes with cardiovascular disease, all-cause mortality, and cardiovascular mortality in American adult male patients with dyslipidemia: the U.S. National Health and Nutrition Examination Survey, 2001 to 2016
by: Xuanfeng Tang, et al.
Published: (2023-10-01)

Evaluation of Energy Performance Indicators and Energy Saving Opportunities for the Italian Rubber Manufacturing Industry
by: Matteo Piccioni, et al.
Published: (2024-03-01)

A cognitive control approach to interference mitigation in communications-based train control (CBTC) co-existing with passenger information systems (PISs)
by: Hongwei Wang, et al.
Published: (2017-11-01)

SOSIALISASI DAN HARMONISASI GERAKAN MASYARAKAT HIDUP SEHAT (GERMAS) DAN PROGRAM INDONESIA SEHAT DENGAN PENDEKATAN KELUARGA (PIS-PK) DI KOTA SUKABUMI
by: Elsye Rahmawaty, et al.
Published: (2019-05-01)

Mythology of the Law and Justice Party’s Migration Discourse
by: Olena Yermakova
Published: (2019-12-01)

We are Legend
by: Julian W. Tang
Published: (2008-09-01)

The role of thyroid hormones in carotid arterial wall remodeling in women
by: Saric Maida Seferovic, et al.
Published: (2022-03-01)

Gestational Diabetes Mellitus and Dyslipidemia in HIV-Infected Pregnant Women Receiving PIs Based HAART
by: Natthawut Wetchittichareon, et al.
Published: (2013-03-01)

Private Hospital Energy Performance Benchmarking Using Energy Audit Data: An Italian Case Study
by: Daniele Dadi, et al.
Published: (2022-01-01)

Characterization of low level viraemia in HIV-infected patients receiving boosted protease inhibitor-based antiretroviral regimens
by: Francesca Ferretti, et al.
Published: (2019-09-01)